The 36-month beta value for ARVN is also noteworthy at 1.73. There are mixed opinions on the stock, with 12 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.”
The average price estimated by analysts for ARVN is $63.29, which is $39.52 above than the current price. The public float for ARVN is 52.05M, and at present, short sellers hold a 5.31% of that float. The average trading volume of ARVN on September 15, 2023 was 379.97K shares.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
ARVN) stock’s latest price update
The stock of Arvinas Inc. (NASDAQ: ARVN) has decreased by -5.50 when compared to last closing price of 26.73. Despite this, the company has experienced a -4.03% fall in its stock price over the last five trading sessions. Seeking Alpha reported 2023-09-04 that Arvinas focuses on protein degradation therapies, with current projects targeting breast and prostate cancers. Financially, ARVU holds robust liquidity, minimal debt, and a cash runway till 2026; combined with encouraging preliminary therapeutic results. Given Arvinas’ solid financials and promising therapy potential, the investment recommendation is ‘Buy’ for risk-tolerant, biotechnology-focused investors.
ARVN’s Market Performance
Arvinas Inc. (ARVN) has experienced a -4.03% fall in stock performance for the past week, with a 2.60% rise in the past month, and a -14.08% drop in the past quarter. The volatility ratio for the week is 5.49%, and the volatility levels for the past 30 days are at 4.80% for ARVN. The simple moving average for the last 20 days is -5.40% for ARVN stock, with a simple moving average of -12.03% for the last 200 days.
Analysts’ Opinion of ARVN
Many brokerage firms have already submitted their reports for ARVN stocks, with Oppenheimer repeating the rating for ARVN by listing it as a “Outperform.” The predicted price for ARVN in the upcoming period, according to Oppenheimer is $95 based on the research report published on June 26, 2023 of the current year 2023.
ARVN Trading at 1.04% from the 50-Day Moving Average
After a stumble in the market that brought ARVN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -56.42% of loss for the given period.
Volatility was left at 4.80%, however, over the last 30 days, the volatility rate increased by 5.49%, as shares surge +4.04% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.14% upper at present.
During the last 5 trading sessions, ARVN fell by -4.03%, which changed the moving average for the period of 200-days by -37.38% in comparison to the 20-day moving average, which settled at $26.75. In addition, Arvinas Inc. saw -26.16% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ARVN starting from Peck Ronald, who sale 1,324 shares at the price of $24.39 back on Aug 11. After this action, Peck Ronald now owns 29,965 shares of Arvinas Inc., valued at $32,289 using the latest closing price.
Houston John G, the President and CEO of Arvinas Inc., sale 5,878 shares at $29.53 during a trade that took place back on Mar 01, which means that Houston John G is holding 917,427 shares at $173,577 based on the most recent closing price.
Stock Fundamentals for ARVN
Current profitability levels for the company are sitting at:
- -200.30 for the present operating margin
- +93.76 for the gross margin
The net margin for Arvinas Inc. stands at -214.99. The total capital return value is set at -38.79, while invested capital returns managed to touch -41.72. Equity return is now at value -55.10, with -24.50 for asset returns.
Based on Arvinas Inc. (ARVN), the company’s capital structure generated 0.97 points at debt to equity in total, while total debt to capital is 0.96. Total debt to assets is 0.43, with long-term debt to equity ratio resting at 0.65. Finally, the long-term debt to capital ratio is 0.65.
When we switch over and look at the enterprise to sales, we see a ratio of 1.44, with the company’s debt to enterprise value settled at 0.01. The receivables turnover for the company is 7.80 and the total asset turnover is 0.09. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.20.
Conclusion
In summary, Arvinas Inc. (ARVN) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
